David Kudrow
California Medical Clinic for Headache(US)
Publications by Year
Research Areas
Migraine and Headache Studies, Trigeminal Neuralgia and Treatments, Sympathectomy and Hyperhidrosis Treatments, Psychosomatic Disorders and Their Treatments, Olfactory and Sensory Function Studies
Most-Cited Works
- → ARISE: A Phase 3 randomized trial of erenumab for episodic migraine(2018)583 cited
- → Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial(2014)372 cited
- → Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial(2020)339 cited
- → Sumatriptan-Naproxen for Acute Treatment of Migraine(2007)271 cited
- → Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study(2016)250 cited
- → Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraine(1997)156 cited
- → A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine(2018)141 cited
- → Rotigotine improves restless legs syndrome: A 6‐month randomized, double‐blind, placebo‐controlled trial in the United States(2010)114 cited
- → Eletriptan in the Early Treatment of Acute Migraine: Influence of Pain Intensity and Time of Dosing(2005)105 cited
- → Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine(2020)98 cited